Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002112109 | SCV002389487 | likely benign | not provided | 2024-11-09 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004976239 | SCV005579848 | uncertain significance | Inborn genetic diseases | 2024-07-30 | criteria provided, single submitter | clinical testing | The c.3675T>A (p.N1225K) alteration is located in exon 1 (coding exon 1) of the FAT4 gene. This alteration results from a T to A substitution at nucleotide position 3675, causing the asparagine (N) at amino acid position 1225 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005025698 | SCV005657899 | uncertain significance | Van Maldergem syndrome 2; Hennekam lymphangiectasia-lymphedema syndrome 2 | 2024-06-14 | criteria provided, single submitter | clinical testing |